EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome-Wide Characterisation of Somatic Mutations Across COSMIC Cancer Cell Lines Enables Gene-Centric Experimental Model Selection

Ali F Alsulami iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ali F Alsulami. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Mutation, Neoplasms. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdulaziz University, Deanship of Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cell lines are widely used to investigate cancer-associated mutations and evaluate candidate therapeutic compounds, but selecting an appropriate model carrying a specific mutation can be challenging. A genome-wide analysis of somatic mutations across 1020 human cancer cell lines from the COSMIC Cell Lines Project was performed to establish a gene- and variant-centric approach for experimental model selection. Transcript-specific annotations were normalised to gene symbols, and redundant transcript-derived records were removed. The resulting dataset contained 3,937,879 unique somatic mutation events affecting 18,885 genes, including 95,307 mutation events across 579 Cancer Gene Census Tier 1 genes. Substantial variation in mutation burden was observed among cell lines, while recurrent cancer-associated genes, including TP53, KRAS, BRAF, EGFR and PIK3CA, were represented across multiple models. Importantly, the cell line containing the greatest number of alterations in a cancer-associated gene did not necessarily carry the specific driver mutation required for a particular experimental question. Representative driver variants were therefore used to demonstrate a variant-centric selection strategy in which cell lines carrying the specific alteration of interest are identified rather than models being selected solely according to gene-specific mutation count. This approach distinguishes descriptive gene-level mutation ranking from variant-specific experimental model selection and provides a systematic framework for identifying genetically appropriate candidate cell lines for functional studies and compound testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationNeoplasmsHumansCell Line, TumorGenome-Wide Association StudyGenome, Human

Stichwörter der Autor:innen

COSMIC Cell Lines ProjectCancer Gene Censuscancer cell linesexperimental model selectionhotspot mutationsprecision oncologysomatic mutations

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

ORCID-Profile: Ali F Alsulami

Förderung

  • King Abdulaziz University
  • Deanship of Scientific Research

Zitieren

APA

Alsulami, A. F. (2026). Genome-Wide Characterisation of Somatic Mutations Across COSMIC Cancer Cell Lines Enables Gene-Centric Experimental Model Selection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198636

Vancouver

Alsulami AF. Genome-Wide Characterisation of Somatic Mutations Across COSMIC Cancer Cell Lines Enables Gene-Centric Experimental Model Selection. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198636

BibTeX
@article{Alsulami2026,
  author = {Alsulami, Ali F},
  title = {Genome-Wide Characterisation of Somatic Mutations Across COSMIC Cancer Cell Lines Enables Gene-Centric Experimental Model Selection},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198636}
}
Kostenlos starten →